Meeting of the Advisory Committee on Minority Health, 3159-3160 [2021-00660]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
Responses: 443; Total Annual Hours:
111. (For policy questions regarding this
collection contact Caroline Gallaher at
410–786–8705.)
Dated: January 11, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff,Office of
Strategic Operations and Regulatory Affairs.
[FR Doc. 2021–00762 Filed 1–13–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers CMS–10147]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
March 15, 2021.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26, –05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10147—Medicare Prescription
Drug Coverage and Your Rights
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare
Prescription Drug Coverage and Your
Rights; Use: Section 423.562(a)(3) and
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
3159
an associated regulatory provision at
§ 423.128(b)(7)(iii) require that Part D
plan sponsors’ network pharmacies
provide Part D enrollees with a printed
copy of our standardized pharmacy
notice ‘‘Medicare Prescription Drug
Coverage and Your Rights’’ (hereafter,
‘‘notice’’) if an enrollee’s prescription
cannot be filled.
The purpose of this notice is to
provide enrollees with information
about how to contact their Part D plans
to request a coverage determination,
including a request for an exception to
the Part D plan’s formulary. The notice
reminds enrollees about certain rights
and protections related to their
Medicare prescription drug benefits,
including the right to receive a written
explanation from the drug plan about
why a prescription drug is not covered.
Through delivery of this standardized
notice, a Part D plan sponsor’s network
pharmacies are in the best position to
inform enrollees at point of sale about
how to contact their Part D plan if the
prescription cannot be filled. Form
Number: CMS–10147, OMB 0938–0975;
Frequency: Annually; Affected Public:
Private Sector, Business or other forprofits; Number of Respondents: 70,000;
Number of Responses: 49,681,292; Total
Annual Hours: 827,690. (For questions
regarding this collection, contact Trevor
Rose at (410) 786 7768.)
Dated: January 8, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2021–00587 Filed 1–13–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Minority Health
Office of Minority Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice of meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS or Department) is hereby
giving notice that the Advisory
Committee on Minority Health (ACMH)
will hold a meeting. This meeting will
be open to the public. Preregistration is
required for the public to attend the
meeting, provide comments, and/or
distribute printed material(s) to ACMH
members. Information about the meeting
will be posted on the HHS Office of
Minority Health (OMH) website:
SUMMARY:
E:\FR\FM\14JAN1.SGM
14JAN1
khammond on DSKJM1Z7X2PROD with NOTICES
3160
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
www.minorityhealth.hhs.gov.
Information about ACMH activities can
be found on the OMH website under the
heading About OMH, Committees and
Workgroups.
DATES: The ACMH meeting will be held
on Friday, January 29, 2021, from 1:30
p.m. to 2:00 p.m. ET. If the Committee
completes its work before 2:00 p.m., the
meeting will end early.
ADDRESSES: The meeting will be held
virtually and will be accessible by
webcast.
FOR FURTHER INFORMATION CONTACT:
Samuel Wu, Designated Federal Officer,
Advisory Committee on Minority
Health, Office of Minority Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Suite 100, Rockville,
Maryland 20852. Phone: 240–453–6173;
email: OMH-ACMH@hhs.gov.
SUPPLEMENTARY INFORMATION: In
accordance with Public Law 105–392,
the ACMH was established to provide
advice to the Deputy Assistant Secretary
for Minority Health on improving the
health of each racial and ethnic
minority group and on the development
of goals and specific program activities
of the OMH.
The purpose of the January 2021
ACMH meeting is to finalize
recommendations for improving access
to and utilization of clinical preventive
services among racial and ethnic
minority populations. The
recommendations will be given to the
Deputy Assistant Secretary for Minority
Health to inform efforts for removing
barriers to achieving health equity.
The meeting is open to the public.
Any individual who wishes to attend
the meeting must register by sending an
email to OMH-ACMH@hhs.gov by 5:00
p.m. ET on January 28, 2021. Each
registrant should provide name,
affiliation, phone number, and email
address. Registrants will receive
webcast access information via email.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
contact OMH-ACMH@hhs.gov and
reference this meeting. Requests for
special accommodations should be
made at least ten (10) business days
prior to the meeting.
Members of the public will have an
opportunity to provide comments at the
meeting. Public comments will be
limited to two minutes per speaker
during the time allotted. Individuals
who would like to submit written
statements should email OMH-ACMH@
hhs.gov at least five (5) business days
prior to the meeting.
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
Any members of the public who wish
to distribute electronic or printed
material(s) related to this meeting’s
topic to ACMH members should email
the Designated Federal Officer at OMHACMH@hhs.gov. The material should be
received by the Designated Federal
Officer at least five (5) business days
prior to the meeting.
[FR Doc. 2021–00576 Filed 1–13–21; 8:45 am]
Dated: January 11, 2021.
Samuel Wu,
Designated Federal Officer, Advisory
Committee on Minority Health.
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4150–29–P
Proposed Collection; 60-Day Comment
Request Data and Specimen Hub
(DASH) (Eunice Kennedy Shriver
National Institute of Child Health and
Human Development)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
National Institutes of Health
ACTION:
National Institute on Drug Abuse;
Notice of Closed Meeting
SUMMARY:
[FR Doc. 2021–00660 Filed 1–13–21; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Interventions to Prevent Electronic Nicotine
Delivery Systems (ENDS) Use Among
Adolescents (R01—Clinical Trial Optional).
Date: March 10, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yvonne Owens Ferguson,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 402–7371, yvonne.ferguson@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
National Institutes of Health,
HHS.
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD), the National
Institutes of Health will publish
periodic summaries of propose projects
to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Regina Bures, Ph.D., Eunice
Kennedy Shriver National Institute of
Child Health and Human Development
(NICHD), National Institutes of Health,
6710B Rockledge Drive, Room 2160,
Bethesda, MD 20817, or call non-tollfree number (301) 496–9485 or Email
your request, including your address to:
NICHD.DASH@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Pages 3159-3160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00660]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Advisory Committee on Minority Health
AGENCY: Office of Minority Health, Office of the Secretary, Department
of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services (HHS or Department) is hereby
giving notice that the Advisory Committee on Minority Health (ACMH)
will hold a meeting. This meeting will be open to the public.
Preregistration is required for the public to attend the meeting,
provide comments, and/or distribute printed material(s) to ACMH
members. Information about the meeting will be posted on the HHS Office
of Minority Health (OMH) website:
[[Page 3160]]
www.minorityhealth.hhs.gov. Information about ACMH activities can be
found on the OMH website under the heading About OMH, Committees and
Workgroups.
DATES: The ACMH meeting will be held on Friday, January 29, 2021, from
1:30 p.m. to 2:00 p.m. ET. If the Committee completes its work before
2:00 p.m., the meeting will end early.
ADDRESSES: The meeting will be held virtually and will be accessible by
webcast.
FOR FURTHER INFORMATION CONTACT: Samuel Wu, Designated Federal Officer,
Advisory Committee on Minority Health, Office of Minority Health,
Department of Health and Human Services, Tower Building, 1101 Wootton
Parkway, Suite 100, Rockville, Maryland 20852. Phone: 240-453-6173;
email: [email protected].
SUPPLEMENTARY INFORMATION: In accordance with Public Law 105-392, the
ACMH was established to provide advice to the Deputy Assistant
Secretary for Minority Health on improving the health of each racial
and ethnic minority group and on the development of goals and specific
program activities of the OMH.
The purpose of the January 2021 ACMH meeting is to finalize
recommendations for improving access to and utilization of clinical
preventive services among racial and ethnic minority populations. The
recommendations will be given to the Deputy Assistant Secretary for
Minority Health to inform efforts for removing barriers to achieving
health equity.
The meeting is open to the public. Any individual who wishes to
attend the meeting must register by sending an email to [email protected] by 5:00 p.m. ET on January 28, 2021. Each registrant
should provide name, affiliation, phone number, and email address.
Registrants will receive webcast access information via email.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
contact [email protected] and reference this meeting. Requests for
special accommodations should be made at least ten (10) business days
prior to the meeting.
Members of the public will have an opportunity to provide comments
at the meeting. Public comments will be limited to two minutes per
speaker during the time allotted. Individuals who would like to submit
written statements should email [email protected] at least five (5)
business days prior to the meeting.
Any members of the public who wish to distribute electronic or
printed material(s) related to this meeting's topic to ACMH members
should email the Designated Federal Officer at [email protected]. The
material should be received by the Designated Federal Officer at least
five (5) business days prior to the meeting.
Dated: January 11, 2021.
Samuel Wu,
Designated Federal Officer, Advisory Committee on Minority Health.
[FR Doc. 2021-00660 Filed 1-13-21; 8:45 am]
BILLING CODE 4150-29-P
